Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep-Oct;79(5):636-42.
doi: 10.5935/1808-8694.20130114.

Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis

[Article in English, Portuguese]
Affiliations
Review

Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis

[Article in English, Portuguese]
Melissa Ameloti Gomes Avelino et al. Braz J Otorhinolaryngol. 2013 Sep-Oct.

Abstract

Recurrent respiratory papillomatosis or recurrent laryngeal papillomatosis is a disease of the larynx caused by human papilloma virus, characterized by verrucous epithelial lesions and usually recurring. In the literature there are several types of treatment, such as surgery to cold, laser and/or use of microdebrider, as of adjuvant therapies; all possible to decrease the permanent sequelae of the disease.

Objective: To review the literature regarding this disease with emphasis on surgical techniques and adjuvant therapies used today.

Method: We used the literature review, through surveys based electronic data in the public domain, to search for articles between 1992-2012, using keywords: papilloma, human papilloma virus infection, larynx, therapeutic, papilloma virus vaccine.

Results: We surveyed 357 articles, of which 49 were used as the basis for this review. Scientific studies indicate a reduction of relapse in most adjuvant therapeutic presented. However, the survey showed different methodologies and samples, which did not allow to compare the types of treatment and adjuvant therapies.

Conclusion: The choice of surgical technique varies among studies, but there is a trend to use the microdebrider. The newer adjuvant therapies, such as cidofovir, quadrivalent vaccine against human papilloma virus and bevacizumab, require further studies.

PubMed Disclaimer

References

    1. Hermann JS, Pontes P, Weckx LL, Fujita R, Avelino M, Pignatari SS. Laryngeal sequelae of recurrent respiratory papillomatosis surgery in children. Rev Assoc Med Bras. 2012;58(2):204–208. - PubMed
    1. Avelino MAG, Ferri RG. In: Manual Prático de Laringologia. 1a. Devitis RA, Tsuji DH, editors. Di Livros Editora; Rio de Janeiro: 2011. Conduta no papiloma laríngeo; pp. 177–184.
    1. Avelino MAG, Gutzman RL, Fujita RR, Pignatari S, Weckx LLM, Pontes P. Estudo do efeito do Cidofovir na papilomatose laríngea recorrente em crianças: relato preliminar. Rev Bras Otorrinolaringol. 2004;70(6):734–738. doi: 10.1590/S0034-72992004000600003. DOI: - DOI
    1. Syrjänen S. Current concepts on human papillomavirus infections in children. APMIS. 2010;118(6-7):494–509. PMID: 20553530. - PubMed
    1. Lee JH, Smith RJ. Recurrent respiratory papillomatosis: pathogenesis to treatment. Curr Opin Otolaryngol Head Neck Surg. 2005;13(6):354–359. doi: 10.1097/01.moo.0000186205.91332.46. DOI: - DOI - PubMed

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources